Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.
about
Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.Association between oral contraceptive use as a risk factor and triple-negative breast cancer: A systematic review and meta-analysis.Oral contraceptives cause evolutionarily novel increases in hormone exposure: A risk factor for breast cancer.MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.Progestin and breast cancer risk: a systematic review.Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single InstitutionBreast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.The Role of Oral Contraceptive Pills on Increased Risk of Breast Cancer in Iranian Populations: A Meta-analysis.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.Safety of medical treatments for endometriosis.Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.Types of oral contraceptives and breast cancer survival among women enrolled in Medicaid: A competing-risk model.History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.Oral Contraceptive Use May Modulate Global Genomic DNA Methylation and Promoter Methylation of APC1 and ESR1Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.
P2860
Q30248838-B9AF9430-B724-4D4A-A82A-D3EE6C61C644Q33857861-7C269154-43B0-4CD0-8F2E-ADE31C7AC275Q33862767-60DA3983-3615-4973-9C45-C28A2E88587BQ34450694-ABAE6DBE-1349-4D84-9B6A-3799C4D23F2DQ35174900-7B9C3246-F9D0-425D-96A4-9BD73D086B9CQ35877473-8A8DAC97-5097-4DE0-B472-70F863749FF9Q36167848-38AA1F39-07B7-46D7-AD98-16952B22FA99Q36494140-3DEAB3E7-C9B3-4D84-87EC-DD1384C0B767Q37552340-57C1B8F8-45C2-40A9-8089-ABCD3F8F09C7Q38538492-DD72FB6A-F72A-4130-8C07-B443D6789AB4Q38635759-59A44288-AD8E-455F-AE17-44DB0722BC6AQ40137431-5F0E7BAB-0F65-48FD-A8A4-904A2F07DA22Q40456484-C2C3F515-021D-48D0-9902-0CDDA80B77D7Q41629178-0E9C0DA6-FD42-41A7-8195-0489F6C15127Q43906208-249130AB-2813-4C9C-9F99-D70AC1AF359BQ47134189-0387F492-3790-4ADF-B83A-43391117C12AQ48212165-B79437EC-DEB7-4A95-A619-9F0CDCE2FD02Q51071316-182795D3-33E6-45DD-B9D4-422094E44AF4
P2860
Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Oral contraceptives and breast ...... lar subtype among young women.
@ast
Oral contraceptives and breast ...... lar subtype among young women.
@en
type
label
Oral contraceptives and breast ...... lar subtype among young women.
@ast
Oral contraceptives and breast ...... lar subtype among young women.
@en
prefLabel
Oral contraceptives and breast ...... lar subtype among young women.
@ast
Oral contraceptives and breast ...... lar subtype among young women.
@en
P2093
P2860
P1476
Oral contraceptives and breast ...... lar subtype among young women.
@en
P2093
Christopher I Li
Elisabeth F Beaber
Janet R Daling
Kathleen E Malone
Mei-Tzu Chen Tang
Peggy L Porter
William E Barlow
P2860
P304
P356
10.1158/1055-9965.EPI-13-0944
P577
2014-03-14T00:00:00Z